NCT04352569Completed
Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia
Efficacy of tDCS in the Treatment of Resistant Auditory Hallucinations in Schizophrenia: A Double Blind, Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 6 Aug 2026
Brief summary (registry, in English)
The regions which are assumed to underlie the pathophysiology of schizophrenia, namely hypoactivity at the prefrontal level and pathological hyperactivity of the associative regions of the language located in the left temporoparietal region. To assess the efficacy of tDCS on auditory hallucinations, the investigators performs an randomized double blind versus placebo trial. In each arms patients will receive two tDCS sessions a day during two weeks.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 25 (actual)
- First submitted
- 27 Oct 2015
- Start date
- 3 May 2016
- Primary completion date
- 31 Mar 2025
- Lead sponsor
- Centre hospitalier de Ville-Evrard, France
- Diseases
- Schizophrenia
- NCT number
- NCT04352569
What you commit to
- Study type: Interventional
- Participants enrolled: 25
- From 3 May 2016 to the primary completion date, 31 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Presence of other psychiatric disorders than schizophrenia (except addiction to tobacco or caffeine ).
- History of severe head trauma or coma.
- History of epilepsy or neurological disorder or a general medical condition.
Other
- Presence of intracranial metallic objects or pacemaker.
- Hospitalized patients without consent.
- pregnant women .
Who the study is looking for
- Schizophrenia according to DSM-V.
- Refractory auditory hallucinations(despite two antipsychotics trials).
- Right-handed patients.
- Written informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| unité de recherche clinique de l'E.P.S de Ville Evrard Coordinator of this site? Confirm its status | Neuilly-sur-Marne | France | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.